EPIZYME, INC. Increase (Decrease) in Inventories
EPIZYME, INC. reported Increase (Decrease) in Inventories of $1.84 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2022-08-09
- EPIZYME, INC. increase (decrease) in inventories for the quarter ending 2022-06-30 was -$2.30M, a 201.19% decline year-over-year.
- EPIZYME, INC. increase (decrease) in inventories for the quarter ending 2022-03-31 was $4.14M, a 4.94% decline year-over-year.
- EPIZYME, INC. increase (decrease) in inventories for the quarter ending 2021-12-31 was $14.71M, a 21.01% decline year-over-year.
- EPIZYME, INC. increase (decrease) in inventories for the quarter ending 2021-09-30 was -$13.11M.
- EPIZYME, INC. increase (decrease) in inventories for fiscal 2021 was $8.22M, a 21.38% decline from fiscal 2020.
- EPIZYME, INC. increase (decrease) in inventories for fiscal 2020 was $10.46M.
- EPIZYME, INC. increase (decrease) in inventories for fiscal 2019 was $0.00.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|---|
| 2022-06-30 | -$2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.84M 10-Q · filed 2022-08-09 | $16.55M derived: sum of 3 quarters · filed 2022-08-09 | $3.44M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2022-03-31 | $4.14M 10-Q · filed 2022-05-10 | $18.85M derived: sum of 2 quarters · filed 2022-05-10 | $5.74M derived: sum of 3 quarters · filed 2022-05-10 | $8.01M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-12-31 | $14.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.59M derived: sum of 2 quarters · filed 2022-03-01 | $3.87M derived: sum of 3 quarters · filed 2022-08-09 | $8.22M 10-K · filed 2022-03-01 | |
| 2021-09-30 | -$13.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$10.84M derived: sum of 2 quarters · filed 2022-08-09 | -$6.48M 10-Q · filed 2021-11-09 | $12.13M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-06-30 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $6.63M 10-Q · filed 2022-08-09 | $25.25M derived: sum of 3 quarters · filed 2022-08-09 | $7.23M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | $4.36M 10-Q · filed 2022-05-10 | $22.97M derived: sum of 2 quarters · filed 2022-05-10 | $4.95M derived: sum of 3 quarters · filed 2022-05-10 | $13.11M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | $18.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $597.00K derived: sum of 2 quarters · filed 2022-03-01 | $8.76M derived: sum of 3 quarters · filed 2022-03-01 | $10.46M 10-K · filed 2022-03-01 | |
| 2020-09-30 | -$18.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$9.86M derived: sum of 2 quarters · filed 2021-11-09 | -$8.16M 10-Q · filed 2021-11-09 | $8.16M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $8.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $9.86M 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | $1.70M 10-Q · filed 2021-05-06 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |